| Firm | Analyst |
|---|---|
|
Baird
|
Vikram Kesavabhotla |
|
Bank of America
|
Allen Lutz |
|
Citi
|
Daniel Grosslight |
|
Cowen
|
Charles Rhyee |
|
DA Davidson
|
Robert Simmons |
|
Deutsche Bank
|
George Hill / Lee Horowitz |
|
Evercore ISI
|
Mark Mahaney |
|
Goldman Sachs
|
Eric Sheridan |
|
Guggenheim
|
Jack Wallace |
|
Jefferies
|
Glen Santangelo |
|
J.P. Morgan
|
Douglas Anmuth |
|
KeyBanc
|
Scott Schoenhaus |
|
Morgan Stanley
|
Craig Hettenbach |
|
Raymond James
|
John Ransom |
|
RBC
|
Sean Dodge |
|
Truist
|
Jailendra Singh |
|
UBS
|
Kevin Caliendo |
|
Wells Fargo
|
Stan Berenshteyn |
GoodRx is followed by the analysts listed. Please note that any opinions, estimates or forecasts regarding GoodRx's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of GoodRx or its management. GoodRx does not by its reference or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.